MIRADOR — 2364934
Application number
2364934
International Registration Number
1825260
Type(s)
Standard Characters
Category
Trademark
CIPO Status
SEARCHED
TM5 status
LIVE/APPLICATION/
Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.
Filed
2024-05-07
International Registration
2024-05-07
Applicant
Mirador Therapeutics, Inc.
4902 Headquarters Point, Suite 300
San Diego, CA 92121
UNITED STATES OF AMERICA
Agent
MARKS & CLERK
33 Yonge Street,
Suite 300
Toronto
ONTARIO M5E1G4
Documents
Index headings
- MIRADOR
Goods (Nice class & Statement)
- 1
- (1) Chemical substances, chemical materials and chemical preparations; active pharmaceutical ingredients, namely, antibodies, proteins and small molecules for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines.
- 5
- (2) Pharmaceutical preparations; diagnostic preparations for medical purposes; monoclonal antibodies; chemical, biological and biochemical reagents for medical or veterinary purposes; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing; diagnostic test kits comprised of medical diagnostic reagents and assays that test for the presence of antigens, pathogens, biomarkers for diseases, or biomarkers for predicting patients' response to therapeutic agents.
- 10
- (3) Medical devices.
Services (Nice class & Statement)
- 42
- (1) Research, development and consultation related thereto in the medical, pharmaceutical research and biotechnology fields; pharmaceutical research and development of pharmaceutical preparations; research and development services in the fields of human and animal pharmaceutical and biotechnology drug development and manufacture; laboratory research services in connection with developing new medicinal products; scientific research, development and consultation services in the fields of immunology, antibodies, vaccines, medicine, biotherapeutics, and therapeutics.
- 44
- (2) Medical services.
Claims
- Priority Filing Date: November 09, 2023, Country or Office: UNITED STATES OF AMERICA, Application No. 98262764 in association with the same kind of goods (1)
- Priority Filing Date: November 09, 2023, Country or Office: UNITED STATES OF AMERICA, Application No. 98262767 in association with the same kind of goods (2)
- Priority Filing Date: November 09, 2023, Country or Office: UNITED STATES OF AMERICA, Application No. 98262768 in association with the same kind of goods (3)
- Priority Filing Date: November 09, 2023, Country or Office: UNITED STATES OF AMERICA, Application No. 98262771 in association with the same kind of services (1)
- Priority Filing Date: November 09, 2023, Country or Office: UNITED STATES OF AMERICA, Application No. 98262773 in association with the same kind of services (2)
Recordals (known also as Footnotes)
CHANGE IN TITLE / CHANGEMENT EN TITRE: TYPE OF CHANGE / GENRE DE CHANGEMENT: Name and Address / Nom et adresse DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2026-05-01 DATE OF CHANGE / DATE DE CHANGEMENT: 2026-04-02 COMMENTS / COMMENTAIRES: From: Mirador Therapeutics, Inc. To: Mirador Therapeutics, Inc.Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2024-05-07 | Registration | |
| International Registration | 2024-05-07 | 2034-05-07 | |
| Created | 2024-11-27 | ||
| Formalized | 2024-11-27 | ||
| Designation Notification - Madrid Protocol | 2024-11-28 | 2026-05-28 | |
| Notification of Possible Opposition Sent | 2025-09-29 | ||
| Search Recorded | 2025-11-28 | ||
| Examiner's First Report | 2025-11-28 | 2026-05-28 | |
| Total Provisional Refusal | 2025-11-28 | 2026-05-28 | |
| Agent Changed | 2026-04-20 | From/De: To/A: 3272 | |
| Amendment to Application | 2026-04-30 | DP:2026-05-01 Effective Date: 2026-04-02 |